It can cause a IL-6 increase through testosterone suppression [44] and disease progression to CRPC through the activation STAT3 pathway in PCa [45], because IL-6 is known to induce epithelial–mesenchymal transition (EMT) leading to PCa invasion [46]. Here, STAT3 is linked to posterior cortical atrophy.